Democracy Dies in Darkness

Anti-malarial drug Trump touted is linked to higher rates of death in VA coronavirus patients, study says

Patients treated with hydroxychloroquine and an antibiotic combination received no benefit in rates of death or in use of a ventilator

By
April 21, 2020 at 4:41 p.m. EDT
President Trump on April 21 said that he would be looking into new studies warning against using hydroxychloroquine to combat the novel coronavirus. (Video: The Washington Post)

An anti-malarial drug President Trump has aggressively promoted to treat covid-19 had no benefit and was linked to higher rates of death for Veterans Affairs patients hospitalized with the novel coronavirus, according to a study, raising further questions about the safety and efficacy of a treatment that has seen widespread use in the pandemic.